Yu Feng

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence

Tianmei Si, Nan Li, Huafei Lu et al. · Journal of Psychopharmacology · 2018 · 18 citations · Full text

Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study

Yu Feng, Tianmei Si, Ke-Rang Zhang et al. · Neuropsychiatric Disease and Treatment · 2015 · 17 citations · Full text

Acute Schizophrenia, Psychiatric Evaluation, Psychotropic Medication +16

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Adam Savitz, Haiyan Xu, Srihari Gopal et al. · Neuropsychiatric Disease and Treatment · 2017 · 15 citations · Full text

Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety

Tianmei Si, Jianmin Zhuo, Ibrahim Turkoz et al. · Expert Opinion on Pharmacotherapy · 2017 · 15 citations

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

Jingping Zhao, Lehua Li, Jianguo Shi et al. · Neuropsychiatric Disease and Treatment · 2017 · 14 citations · Full text